 This is a Bloomberg Money Minute. Quite widespread among many industries right now is excitement surrounding the promise of AI. But perhaps nowhere is excitement greater than in the medicine business. We're doing things that have really never been done before. It's early days, but it's extremely promising. Paul Hudson is CEO of drug giant Sanofi. The more we add AI, the more we improve our decision intelligence, the more opportunity we have to do more in that space. And I think that's what's catching the excitement in our organization.